Polymorphism and smoking in bladder carcinogenesis

Br J Urol. 1996 May;77(5):672-5. doi: 10.1046/j.1464-410x.1996.09748.x.

Abstract

Objective: To study the relationship between smoking, a cytochrome P-450 gene polymorphism and the development of bladder cancer.

Patients and methods: The study comprised 126 patients with a diagnosis of bladder cancer from whom a full history was obtained. Genomic DNA was extracted from blood sampled from each patient and genotyping of the CYP2D6 locus, the gene responsible for debrisoquine hydroxylase activity, was performed using a polymerase chain-reaction technique.

Results: Of the 126 patients, 78% had a history of smoking. There was a relationship between the number of cigarettes smoked and the grade of the presenting bladder tumour; heavy smokers developed high-grade disease. There was a trend for those heterozygous at the CYP2D6 locus and with a history of smoking to develop more aggressive disease, but this trend did not reach statistical significance.

Conclusion: The link between smoking and bladder cancer was confirmed. Furthermore, the grade of the presenting tumour was related to the 'cigarette-years'. The CYP2D6 genotype may influence the type of bladder cancer that develops in smokers.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Cytochrome P-450 Enzyme System / genetics*
  • Female
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Genetic*
  • Smoking / adverse effects*
  • Urinary Bladder Neoplasms / etiology
  • Urinary Bladder Neoplasms / genetics*

Substances

  • Cytochrome P-450 Enzyme System